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Extended-spectrum β-lactamase (ESBL) and/or plasmid-mediated AmpC (pAmpC)-
producing Enterobacteriaceae with co-resistance to fluoroquinolones are increasingly 
identified in food-borne pathogens globally.  This study investigated ESBL- and 
pAmpC-mediated β-lactam resistance as well as plasmid-mediated fluoroquinolone 
resistance in 198 samples taken from 99 frozen chickens (99 samples from the liquid 
thaw and 99 from carcass swabs), Brazil, South Africa and Mozambique each produced 
33 chicken.  Species identification was undertaken using in-house biochemical tests and 
antibiotic susceptibility was ascertained by the disc diffusion test following CLSI 
guidelines.  ESBL production was determined using the double-disk synergy test and 
isolates were subjected to PCR to detect the presence of blaCTX-M, blaSHV, blaTEM, 
blaCMY, blaMOX, blaFOX, blaDHA, qnrB, qnrD, qnrS and qepA genes. A random selection 
of CTX-M genes was sequenced.  The 198 samples yielded 27 putative ESBL-positive 
isolates: Citrobacter diversus (1), Citrobacter freundii (3), Enterobacter aglomerans 
(1), Enterobacter cloacae (1) and Escherichia coli (21). Of the 27 isolates, 19 were 
from South African chicken, five from Mozambican chicken and three from Brazilian 
chicken. Resistance to ampicillin was 100,0%, followed by 88.8% to ceftriaxone, 77.8% 
to trimethoprim-sulphamethoxazole, 74.0% to cefotaxime, 70.4% to ciprofloxacin, 
66.6% to ceftazidime, 22.2% to cefoxitin and 7.6% to gentamicin. Multi-drug resistance 
was evident in 19 (70.4%) isolates, 15 of which were from South Africa. The 
predominant ESBL gene was blaSHV (85%), followed by blaCTX-M (62.9%) and 
blaTEM (44.4%) whilst blaMOX (33, 3%) and blaDHA (33.3%) were the most common 
pAmpC genes.  The predominant plasmid-mediated fluoroquinolone-resistance gene 
was qepA (22.2%). DNA sequencing of the blaCTX-M genes putatively identified blaCTX-
M-55/-79/-101/-164, with blaCTX-M-164 being most common. ERIC–PCR profiles allowed the 
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differentiation of the E. coli and Citrobacter spp. isolates.  There was no strong 
evidence of clonality, however, South African isolates shared more similarity.  qnr and 
qepA genes were predominantly identified in South African E. coli isolates while CTX-
M and SHV genes were prevalent in isolates from diverse origins.  The Mozambican 
population is thus exposed to a reservoir of plasmid-mediated and hence, mobile β-
lactam and fluoroquinolone resistance genes from imported, and to a lesser extent, 
locally-produced chicken. The complexity and diversity of mobile resistance genes 










Antibiotic resistance is considered a global health problem for many decades and has 
now been escalated by World Health Organization (WHO) to one of the top health 
challenges of the 21
st
century (CDC, 2010). 
 
One of the most studied and clinically relevant resistant bacteria is extended-spectrum 
beta-lactamase (ESBL) - producing Enterobacteriaceae. Currently, ESBL-producing 
bacteria are not isolated only in humans but also in food bacteria.  According to Platteel 
et al. (2013) two compartments have been suggested as habitats of ESBL-producing 
Enterobacteriaceae: one in hospitals as a result of cross-contamination and unrelated to 
food consumption, and another in the community as a result of consumption of 
contaminated food. 
 
Some food animals, including chickens, turkeys, pigs and cattle, may be colonized by 
ESBL and/or plasmid-mediated AmpC (pAmpC)-producing E. coli and have been 
considered potential causes of community-acquired diseases (Carattoli, 2008). The 
presence of ESBL producing bacteria in food animals has been reported repeatedly and 
the connection between these bacteria in food animals and humans has been proposed 
(Doi et al. 2010). 
 
Fluoroquinolone resistance in animal food production is also being studied in many 
countries and the use of fluoroquinolones in poultry has been linked to antibiotic-
resistant Campylobacter infections in humans. Enrofloxacin is the most commonly used 
fluoroquinolone for colibacillosis (Chu et al.   2004). 
 
Antimicrobial agents are essential tools for protecting animal health and welfare, and 
they also contribute to satisfying the increasing world demand for safe food of animal 
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origin, such as milk, meat, fish and eggs. Although, antimicrobial agent use in animal is 
permitted, it is essential that such use is responsible and prudent (OIE, 2013). 
 
According to the World Organization for Animal Health (OIE) the third and fourth 
generation cephalosporins, and fluoroquinolones are important for human and animal 
health and should thus not be used as preventive treatment in feed or water or in absence 
of clinical signs.  They should further not be used as first line treatment unless justified 
and on bacteriological testing (OIE, 2013). 
 
Most studies about ESBL/pAmpC–producing bacteria are related to human samples 
followed by reports in poultry (Ewers, 2012). Contamination of retail chicken meat with 
ESBL-producing Gram-negative bacteria has been reported in several countries (Mesa 
et al. 2006). 
 
In Mozambique, chicken is one of the most consumed foods by the population. It is 
sourced in the formal and informal markets that are supplied by chickens reared 
nationally by aviaries and internationally by the South African and Brazilian firms. The 
national producers of broilers use antibiotics as additives to promote growth, and the 
biggest supplier is Interchemie, from the Netherlands (http://www.interchemie.com/). 
Given the rise of resistant strains in health care facilities, it is deemed appropriate to 
carry out a study to detect the presence of ESBL/pAmpC-producing and 
fluoroquinolone-resistant Enterobacteriaceae in imported and domestically produced 
chicken in Mozambique.  
 
1.2. AIM AND OBJECTIVES 
 
Aim 
To investigate the presence of the ESBL/pAmpC-producing and fluoroquinolone-
resistant Enterobacteriaceae in imported and locally produced chicken and perform 






 To culture bacterial isolates from the liquid thaw and carcass swabs from chicken 
produced in Mozambique, South Africa and Brazil. 
 To identify bacterial isolates from imported and domestically produced 
chickens/poultry to species level 
  To ascertain the antibiotic susceptibility of isolates against an appropriate panel 
of antibiotics by standardized agar disc diffusion  
 To phenotypically confirm the production  of: 
o  ESBLs using the double-disc synergy test,  
o AmpC β-lactamase using the cefoxitin disc sensitivity test, and, 
o Inducible AmpC β-lactamase production using the disk antagonism test.   
 To identify the EBSL and/or pAmpC genes by PCR and sequencing 
 To identify plasmid-mediated quinolone resistance genes (qnrB, qnrD, qnrS and 
qepA) by PCR. 
 To undertake strain typing by ERIC-PCR to ascertain clonal similarities or 
differences at national and international levels 
 To compare the phenotypic and genotypic differences between imported and 






1.3. LITERATURE REVIEW 
 
1.3.1. Resistance as a Public Health Problem 
 
After the discovery of penicillin by Alexander Fleming, several other antibacterial 
agents were developed.  Most of them were developed in the 1970s and then new classes 
in the 1980s. In his Nobel Prize speech, Fleming warned that bacteria could become 
resistant to penicillin (WHO, 2014). 
 
In 2000, WHO considered the increase of antimicrobial resistance a global crisis and in 
the following year it released its first global strategy for its containment (WHO, 2001). 
Antimicrobial resistance is a public health problem that has many implications to the 
lives of humans, because it is a growing threat to the effective treatment of an ever-
increasing range of infections, by bacteria, parasites, virus and fungi which reduce 
efficacy of antibacterial, anti-parasitic, anti-viral and anti-fungal agents respectively 
making the treatment of patients difficult, costly, and at times impossible. All these 
factors can result in prolonged illness and increased mortality (WHO, 2014).  
 
From the 1980s, researchers began to notice that certain bacterial strains had become 
resistant to antibiotics used in poultry and the continued use of antimicrobials as growth 
promoters had increased a "pool" of resistance genes in nature (Sader, 2004) with 
concern on the possibility of transmission of this resistance from poultry to humans. 
 
The World Health Organization (WHO), the World Organization for Animal Health 
(OiE) and the Food and Agriculture Organization of the United Nations (FAO) entered 
into a tripartite alliance to address AMR in 2015. This collaboration reflects the “One 
Health” approach, which emphasizes the interconnectedness of the health of humans, 
animals and ecosystems. The OIE Strategy on Antimicrobial resistance (AMR) and the 
Prudent Use of Antimicrobials has four main objectives, viz.,“(1) improve awareness 
and understanding; (2) strengthen knowledge through surveillance and research; (3) 
support good governance and capacity building; and, (4) encourage implementation of 
international standards” (OIE, 2016).  The FAO’s Action Plan on AMR 2016-2020 also 
has 4 focus areas, viz., “(1) improve awareness on AMR and related threats; (2) develop 
capacity for surveillance and monitoring of AMR and AMU (antimicrobial use) in food 
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and agriculture; (3) strengthen governance related to AMU and AMR in food and 
agriculture; and, (4) promote good practices in food and agricultural systems and the 
prudent use of antimicrobials” (FAO, 2016).  This study speaks to objective 2 and focus 
area 2 of the OIE and FAO strategies respectively.   
 
1.3.2. Potential Sources and Reservoirs of Resistant Bacteria  
 
Potential sources for the acquisition/transmission of ESBL and AmpC-producing 
Enterobacteriaceae are: foodborne, direct animal-to-human transmission, human-to-
human transmission, environment and infections obtained abroad during travelling 
(Carmo et al. 2014). 
 
The use of antibiotics as growth promoters and to prevent infection in farm animals 
rather than cure infections is responsible for drug-resistant bacteria emerging on farms 
which reaches the population through human or animal carriers and food (Todar, 2014).  
Some of the antibiotic resistance genes identified in food bacteria have also been 
identified in humans, providing indirect evidence for transfer by food handling and/or 
consumption (Marshall and Levy, 2011). 
 
The increasing levels of bacterial resistance, in particular strains of Salmonella 
typhimurium observed in 1963 at several British feed lots, led to confirmation that the 
indiscriminate use of antibiotics in agriculture is a major cause of the increase in 
antibiotic resistant bacteria (Dewey et al. 1997).  Anderson et al. (2003) reported that 
using antibiotics similar to those used in human medicine as growth promoters and in 
the treatment of animals increases the possibility of resistant pathogenic bacteria whose 
reservoirs in food animals develop cross-resistance to antimicrobial used in the 
treatment of infectious diseases in humans. 
 
ESBL and AmpC-producing Enterobacteriaceae were initially only observed in 
humans, but in recent studies these bacteria are observed in companion animals and 
increasingly in livestock (Ewers, 2011). The ESBL and AmpC produced by E. coli are 
being found frequently in food-producing animals (Smet et al. 2010). According to 
Ewers (2012), this finding leads to the hypothesis that animals might become infection 




Companion animals also represent potential sources of the spread of multidrug-resistant 
bacteria (Dos Santos et al. 2013).  This is supported by Meyer and collaborators (2012) 
in a study which showed that previous contact with pets increases by almost seven-fold 
the possibility to be colonized with ESBL positive bacteria (Meyer et al. 2012).  Pets 
are considered as reservoirs of resistant bacteria (Costa et al. 2008). The animals that 
have close contact with humans, like dogs and cats, may share microbiota with humans 
suggesting an important reservoir of resistant bacteria (Dos Santos et al. 2013). 
 
The resistance observed in chickens, pigs and cattle can be transmitted to humans via 
the food chain in the human intestine (Salyers et al. 2004). The poultry industry has 
been considered a potential reservoir of ESBL-producing Gram-negative bacteria that 
may be acquired by humans through handling or consumption of contaminated meat 
(Leverstain-van Hall et al. 2011). 
 
In the Netherlands, the prevalence of ESBL-producing E. coli in gastrointestinal tract of 
healthy food-producing animals, especially in poultry, increased from 3% in 2003 to 
15% in 2008 and in 2009 ESBL–producing bacteria were detected in all 26 broiler 
farms studied (Dierikx, 2010). 
 
1.3.3. Beta-lactam Antibiotics 
 
1.3.3.1. Beta-lactam Antibiotics Classes 
The beta-lactam antibiotics contain the four-membered, nitrogen-containing, beta-
lactam ring at the core of their structure (Forbes et al. 2007) and their classes are inter 
alia penicillin, amino-penicillins, ureido-penicillins, cephalosporins, beta-lactamase 
inhibitor combinations; monobactams, cephamycins,  and carbapenems (CDC, 2013). 
 
The beta-lactam antibiotics are the largest group of antibacterial agents, and dozens of 
derivatives are available for clinical use.  Their popularity results from targeted bacterial 
action and their low toxicity to humans. Also, their molecular structure can be 





1.3.3.2. Mechanism of Action  
 
The beta-lactam ring is key to the mode of action of these groups of drugs that target 
and inhibit cell walls synthesis by binding the enzymes involved in synthesis. The 
essential enzymes for this action are anchored in the cell membrane and as a group are 
referred to as penicillin-binding proteins (PBPs). When beta-lactams bind to these 
PBPs, cell walls synthesis is essentially halted. Death results from osmotic instability 
caused by faulty cell wall synthesis, or the binding of the beta-lactam to PBP may 
trigger a series of the events that lead to autolysis and death (Forbes et al. 2007). 
 
1.3.3.3. Beta-lactam Antibiotic Resistance 
 
Pathogens create mechanisms that destroy or inactivate the antibiotics to avoid 
destruction by the antibiotics. According to Zemelman et al. (2002) in this type of 
mechanism, the most classical example is β-lactamase which, acts by destroying the β-
lactam ring of penicillins and cephalosporins. 
 
ESBL are plasmid-encoded enzymes most commonly found in the bacterial family 
Enterobacteriaceae, especially in E. coli and Klebsiella pneumonia (EFSA, 2011). Over 
time, this type of resistance has been observed in other species of the family 
Enterobacteriaceae (including Enterobacter spp., Serratia spp. and Proteus mirabilis) 
and other genera, such as Pseudomonas aeruginosa (Winn et al. 2010). AmpC beta-
lactamases are intrinsic cephalosporinases found on the chromosomal DNA of many 
Gram-negative bacteria. However, the number of AmpC enzymes that are plasmid 
borne is increasing (EFSA, 2011).  ESBL enzymes and AmpC enzymes differ from 
each other in their ability to hydrolyze the different beta-lactam antibiotics. ESBLs 
hydrolyze 3
rd
 and sometimes 4
th
 generation cephalosporins and monobactams and are 
inhibited by clavulanic acid and cephamycins (Ewers, 2012). AmpC beta-lactamases 
hydrolyze 3
rd
 generation cephalosporins and cephamycins, but not the 4
th
 generation 
cephalosporins and they are not inhibited by clavulanic acid (Jacoby, 2009).  
 
Until the 1990s, the ESBL frequently identified in human clinical isolates were SHV or 
TEM (Pitout, 2012) but CTX-M enzymes have become the most widespread type 
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(Pitout and Laupland, 2008). Over the last years special genes belonging to the CTX-M 
family are emerging rapidly worldwide (Ewers, 2012). 
 
Numerous studies have described the occurrence of E. coli producing ESBL in food-
producing animals, and strains relevant to human health are also increasingly being 
isolated from companion animals. The most frequent genes associated with this 
resistance among food producing animals and companion animals encode various CTX-
M enzymes, followed by blaTEM-52 and blaSHV-12 (Ewers et al. 2011). Among CTX-M 
enzymes, the most frequent types found in humans, companion animals, poultry, cattle 
and pigs are CTX-M-1, CTX-M-14 and CTX-M-15 (Ewers et al. 2012). 
 
The most important gene families encoding AmpC beta-lactamases are CMY, ACC, 
DHA and FOX, with CMY being the most predominant family and blaCMY-2 as the 
most predominant gene (Jacoby, 2009). 
 
1.3.3.4. Resistance to beta-lactam antibiotics in food animals  
 
ESBL and/or pAmpC-producing isolates can be found in nearly all food-producing 
animals (Carattoli, 2008). One of the earlier descriptions of the poultry carriers of ESBL 
and pAmpC was made by Briñas and collaborators (2003) who observed CTX-M-14, 
SHV-12 and CMY-2 producing E. coli in the feces of healthy chickens in Spain 
between 2000 and 2001 (Briñas et al. 2003). 
  
In 1999 to 2000, the isolation of bacteria carrying CTX-M-14, CTX-M-2 and CMY-2 
from healthy poultry was reported in Japan (Kojima et al. 2005). A study performed by 
Kolar and his collaborators in 2010 which aimed to detect ESBL and AmpC beta-
lactamase-producing Enterobacteriaceae in poultry in the Czech Republic, showed that 
the most frequent ESBL types were CTX-M-1 and SHV-12 and the most common 
AmpC enzymes were the CMY-2 types (Kolar et al. 2010). 
 
 A study carried out by Leverstain-van Hall and collaborators in 2011, which aimed to 
determine whether retail chicken shared the same ESBL genes, plasmids and strains as 
those found in Dutch patients, showed that 94% of a representative sample of chicken 
meat was contaminated with ESBL-producing E. coli, of which 39% belonged to 
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genotypes also found in human samples (Leverstain-van Hall et al. 2011). Similar 
results were found by Kluytmans et al. (2013), in a study performed in Netherlands 
which aimed to compare the ESBL-producing E. coli strains, plasmids, resistance genes 
and virulence factors from retail chicken meat and humans, where significant genetic 
similarities among ESBL- producing E. coli from chicken meat and humans was 
observed with respect to mobile resistance elements, virulence genes and the genetic 
backbone (Kluytmans et al. 2013). 
 
E. coli strains are one of ESBL-producing bacteria most often isolated in greater 
numbers in food-producing animals (Smet et al. 2010). Some European countries have 
reported ESBLs in Salmonella isolates, including CTX-M-2, -9, -14 and TEM-52 
(Coque et al. 2008a). 
 
Another study on the identification of ESBL in the United Kingdom found that chicken 
breast fillets imported from Brazil, France, Poland and Netherlands were positive for 
CTX-M-2 producing E. coli (Warren et al. 2008). In another study, E. coli strains 
isolated from raw chicken meat imported from Argentina, Chile and Brazil were found 
to carry blaCTX-M-2 and blaCTX-M-8 (Dhanji et al. 2010).  In Portugal, fecal samples from 
healthy broilers at slaughterhouses, revealed cefotaxime-resistant E. coli producing 
TEM-52, CTX-M-14 and CTX-M-32 (Costa, 2009).  In a study performed on fecal 
samples of healthy and sick poultry in Spain, E. coli strains were found to harbor 
blaCTX-M-14, blaCTX-M-9, or blaSHV-12 genes (Briñas, 2003).  A study performed in Italy in 
farms E. coli isolates with reduced susceptibility to cefotaxime or ceftiofur from healthy 
broilers confirmed the presence of blaCTX-M-1, blaCTX-M-32, blaSHV-12 (Bortolaia et al. 
2010).  In Switzerland, CTX-M-1, SHV-12 and TEM-52 ESBLs were detected in E. 
coli strains recovered from fecal samples of healthy chickens (Geser et al. 2012). 
  
Results from several countries indicate that the bacteria mostly frequently isolated is E. 
coli and the most common genes are CTX, SHV and TEM (Geser et al. 2012; Briñas et 
al. 2003). Most of the studies on the presence of ESBL and/or pAmpC-producing 
bacteria in food-producing animals, especially in poultry, were conducted in Europe and 





1.3.4. Fluoroquinolone Antibiotics 
 
1.3.4.1. Fluoroquinolones  
 
Fluoroquinolones, also often simply referred to as quinolones, are potent bactericidal 
agents.  They have a broad spectrum of activity that includes Gram-negative and Gram-
positive bacteria (Forbes et al. 2007). 
 
Nalidixic acid was the first quinolone introduced to human medicine in 1962. Over the 
past 20 years numerous fluorinated derivatives of nalidixic acid have been developed. 
The addition of a fluorine molecule at position 6 of the basic quinolone nucleus 
enhanced the spectrum and potency of quinolone activity and increased penetration into 
the bacterial cell (Sweet and Gibbs, 2012). 
 
1.3.4.2. Mechanism of Action of Fluoroquinolones 
 
The fluoroquinolone antibiotics kill susceptible bacteria by inhibiting DNA synthesis 
secondary to direct effect on two members of the topoisomerase class of enzymes, DNA 
gyrase and topoisomerase IV, promoting the cleavage in these enzyme-DNA 
complexes. The spectrum of activity of the fluoroquinolone is wide. Enterobacteriaceae 
family are generally highly susceptible to the fluoroquinolones with MIC values of 
0.5µg/mL or less (Sweet and Gibbs, 2012; CLSI, 2014). 
 
1.3.4.3. Fluoroquinolone Resistance 
 
The chromosomally encoded resistance was the first mechanism of quinolone resistance 
characterized. This mutation is classified in two groups: (1) mutation located within the 
target genes decreasing the interaction between the quinolone drug and the intermediate 
DNA-gyrase complex and (2) mutation that affect the intracellular levels of quinolone 
drugs (Santamaria, 2010). 
 
Quinolone resistance was initially associated with the mutations in the target genes. 
These chromosomal mutations generally cluster within the quinolone resistance-
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determining regions (QRDRs) and the regions that have been characterized in each of 
the four target genes: gyrA, gyrB, parC and parE (Eaves et al. 2004). 
 
In the Enterobacteriaceae family, E. coli and Salmonella typhimurium are the best 
characterized for quinolone resistance. In this bacterial group, the most important 
mutation triggering a quinolone resistance phenotype occurs in the gyrA gene (Chen et 
al. 2007). 
 
The second mechanism of resistance is a decrease in intracellular accumulation of the 
antibiotic. The related modifications trigger further increases in the MICs of quinolones 
and can modulate the final MIC when one or several QRDR mutations have been 
initially acquired. This mechanism can be associated with:(1) an up-regulation of efflux 
pumps, which are energy-dependent efflux systems localized in the cell enveloped that 
can expel quinolone drugs and (2) a decrease in permeability related to decreased 
expression of porins, which are outer membrane proteins and are only present in Gram-
negative bacteria (Jacoby, 2005). 
 
The horizontal transmission of quinolone plasmid-mediated resistance was reported in 
the 1990s. There are four types of genes of transferable quinolone resistance 
characterized, i.e., qnr, aac(6´)-Ib-cr, qepA and oqxAB related to three different 
mechanisms, i.e. enzyme protection, drug inactivation and  efflux respectively 
(Strahilevitz, 2009). 
 
The first plasmid-mediated mechanism of resistance to quinolones was described in 
1998 (Martinez-Martinez, 1998) which was due to the QnrA protein that belongs to the 
penta-peptide repeat family (Tran, 2005). The second mechanism of quinolone 
resistance was described in 2006 as enzymatic inactivation of certain quinolones, 
representing a new mechanism of quinolone resistance. The acc (6´)-IB genes encodes 
an aminoglycoside acetyltransferase that modifies aminoglycosides and 
fluoroquinolones preventing their interaction with targets (Strahilevitz, 2009). 
 
In 2007, a plasmid-encoded efflux pump, QepA, was found in plasmids from 
Enterobacteriaceae. QepA is associated with an increase of 2-, 32- and 64-fold increase 
in the MICs of nalidixic acid, norfloxacin and ciprofloxacin, respectively, and differs 
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from chromosomally encoded quinolone efflux pumps that frequently have a wider 
range of substrates (Kim, 2009). 
 
OqxAB is another plasmid-encoded quinolone efflux pump that was first described as 
conferring resistance to the swine growth enhancer olaquindox (Hansen, 2004). This 
determinant is multidrug efflux pump, belonging to the resistance-nodulation-division 
(RND) family of bacterial transporters and capable of effluxing quinolones among other 
drugs (Hansen, 2007). 
 
1.3.4.4. Resistance to Fluoroquinolones in Food Animals 
 
The fluoroquinolones used to treat sick food animals create selection pressure for the 
consequent development of resistant bacteria in humans, which include resistant strains 
of Campylobacter spp., E. coli and Salmonella spp. (Collignon, 2005; Chu et al. 2004). 
 
Before fluoroquinolone were used in farming, no humans without prior exposure to the 
drugs were known to carry fluoroquinolone-resistant Campylobacter spp. (Witte, 1998). 
After the introduction of this antibiotic in food producing animals, fluoroquinolone-
resistance was observed with a tendency of increasing over time. For example, in 1991 
when fluoroquinolones were first approved for use in poultry in the UK, just 1% of 
birds carried fluoroquinolone-resistant Campylobacter spp. (Endtz, 1991) and in 2008, 
18% of C. jejuni and 25 of C. coli taken from chickens during an abattoir survey were 
ciprofloxacin resistant (EFSA, 2010). 
 
In a study performed by Li et al. (2014), which aimed to explore prevalence and 
characteristics of ESBL and plasmid-mediated fluoroquinolone resistance genes in E. 
coli in China involving 202 isolates, 37.1% possessed plasmid-mediated quinolone 
resistance determinants. In these determinants, positive rates for qnr genes and acc (6´)-
IB-cr were 10.4% and 32.2 %, respectively (Li et al. 2014). 
 
Antibiotic resistance in recent years has increased dramatically, and is thus considered a 
public health problem. Initially, the strains were observed only in humans.  However, 
currently, they are observed in food animals, in pets as well as in agricultural settings. 
Various studies have shown that resistant strains can pass from animals to humans 
22 
 
through the food chain, as well as by contact, like caregivers of animals, however, the 
mechanism is not known. Several studies in this area have been performed in Europe, 
America and Asia, but are scarce in Africa and absent in Mozambique. This study will 
provide a Mozambican perspective on ESBL and pAmpC-producing and 




Anderson A. D., Jennifer M. N., Shannon R, Frederick J. A. (2003) Public Health 
Consequences of Use of Antimicrobial Agents in Food Animals in United States. 
Microbial Drug Resistance. 9. p. 373-379. 
Bortolaia V., Guardabassi L., Trevisani M, Bisgaard M., Venturi L., Bojesen A. M. 
(2010) High diversity of extended-spectrum beta-lactamases in Escherichia coli isolates 
from Italian broiler flocks. Antimicrobial Agents and Chemotherapy. 54. p. 1623-1626. 
Briñas L., Moreno M. A., Zarazaga M., Porrero M. C., Sáenz Y., Garcia M., Domingues 
L., Torres C. (2003) Detection of CMY-2, CTX-M-14 and SHV-12 β-lactamases in 
Escherichia coli strains from healthy chickens. Antimicrobial Agents and 
Chemotherapy. 47. p. 2056-2058. 
Carmo L. P., Nielsen L. R., da Costa P. M., Alban L. (2014) Exposure assessment of 
extended-spectrum beta-lactamases/AmpC beta-lactamases-producing Escherichia coli 
in meat in Denmark. Infection Ecology and Epidemiology. 4. p. 22924-229234. 
 
Carattoli A. (2008) Animal reservoirs for extended spectrum beta-lactamase producers. 
Clinical Microbiology and Infection.14. p. 117–123. 
 
Centers for Disease Control and Prevention (CDC). (2013) Antibiotic resistance threats 
in the United States. [Online], Available from:www.cdc.gov/drugresistance/threat-
report-2013/.../ar-threats-2013-508.p. [Accessed: 17
th
 April 2015] 
Centers for Disease Control and Prevention (CDC). (2010) Get smart: know when 
antibiotics work. [Online], Available from: www.cdc.gov/Features/GetSmart. 
[Accessed: 18
th
 May 2015]. 
23 
 
Chen S, Cui S., McDermott P. F., Zhao S., White D. G., Paulsen I., Meng J. (2007) 
Contribution of target gene mutation and efflux to decreased  susceptibility of 
Salmonella enterica serovar Typhimurium to Fluoroquinolones and other antimicrobials. 
Antimicrobial Agents and Chemotherapy. 51. p.335-352. 
 
Chu Y.W., Chu M.Y., Luey K.Y., Ngan Y.W., Tsang K. L., Kam K. M. (2004) Genetic 
relatedness and quinolone resistance of Campylobacter jejuni strains isolated in 2002 in 
Hong Kong. Journal of Clinical Microbiology. 42. p.3321–3323. 
 
Clinical and Laboratory Standard Institute (CLSI). (2014) Performance Standards for 
Antibiotic Susceptibility Testing: Twenty-fourth informational supplement, M100-S24, 
Table 2A Enterobacteriaceae, M02 and M07, 2014. Vol.34 N0.1. Available from: 




Collignon P. (2005) Fluoroquinolone Use in Food Animals. Emerging Infectious 
Disease. 11(11). p. 1789-1792 
Coque T. M., Baquero F., Canton R. (2008) Increasing prevalence of ESBL-producing 
Enterobacteriaceae in Europe. Eurosurveillance. 13 (pii).19044-19055. 
Costa D., Poeta P., Sáenz Y., Coelho A. C., Matos M., Vinué L., Rodrigues J., Torres C. 
(2008) Prevalence of antimicrobial resistance and resistant genes in faecal Escherichia 
coli isolates recovered from healthy pets. Veterinary Microbiology. 127. p. 97-105. 
Costa D., Vanue L., Poeta P. Y., Coelho A. C., Matos M., Sáenz Y., Somalo S., 
Zarazaga M., Rodrigues J., Torres C. (2009) Prevalence of extended-spectrum beta-
lactamases-producing Escherichia coli isolates in fecal samples of broilers. Veterinary 
Microbiology. 138. p.139-344. 
Costa D., Poeta P., Sáenz Y., Coelho A. C., Matos M., Vinué L., Rodrigues J., Torres C. 
(2008) Prevalence of antimicrobial resistance and resistant genes in faecal Escherichia 
coli isolates recovered from healthy pets. Veterinary Microbiology. 127. p. 97-105. 
Dewey C. E., Cox B. D., Straw B. E., Budh E. J., Hurd H. S. (1997) Association 
between off-label feed additives and farm size, veterinary consulting use and animal 
age. Preventive Veterinary Medicine. 31. p.133-46. 
24 
 
Dhanji H., Murphy N. M., Doumith M., Durmus S., Lee S. S., Hope R., Woodford N., 
Livermore M. D. (2010) Cephalosporin resistance mechanisms in Escherichia coli 
isolated from  raw chicken imported in the UK. Journal of Antimicrobial 
Chemotherapy. 65. p. 2534-2538. 
Dierikx C. M., Fabri T., Good J. A. van der, Molenaar R., Veldimar K. T., Putirulan F. 
F., Mevius D.J. (2010) Prevalence of Extended-Spectrum-Beta-Lactamase producing E. 
coli isolates on broiler farms in the Netherlands. Journal of Antimicrobial 
Chemotherapy. p. 349-357. 
Doi Y., Paterson D. L., Egea P., Pascual A., López-Cerero L., Navarro M. D., Adams-
Haduch J. M., Qureshi Z. A., Sidjabat H. E., Rodríguez-Baño J. (2010) Extended-
spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples 
and retail meat from Pittsburgh, USA and Seville, Spain. Clinical Microbiology and 
Infection. 16. p .33-38. 
  
Dos Santos L., Moura R. A., Aguiar-Ramires P., De Castro A. P., Lincopan N. (2013) 
Current status of extended-spectrum β-lactamase (ESBL)-producing 
Enterobacteriaceae in animals. Microbiology. 4. p.1600-1607. 
Eaves D. J., Randall L., Gray D. T., Buckley A., Woodward M. J., White A. P., Piddock 
L. J. (2004) Prevalence of mutation within Quinolone resistance-determining region of 
gyrA, gyrB, ParC and ParE and association with antibiotic resistance in quinolone-
resistant Salmonella enterica. Antimicrobial Agents and Chemotherapy. 48. p.4012-
4015.  
Endtz H. P., Ruijs G. J., van Klingeren B., JansenW. H., van der Reyden T., Mouton R. 
P. (1991) Quinolone resistance in Campylobacter isolated from man and poultry 
following the introduction of fluoroquinolones in veterinary medicine. Journal of 
Antimicrobial Chemotherapy. 1. p.1197-1199. 
European Food Safety Authority Panel on Biological Hazards (BIOHAZ). (2011) 
Scientific Opinion on the public health risks of bacterial strains producing extended-
spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. 







European Food Safety Authority (EFSA). (2010) The community summary report on 
antimicrobial resistance in zoonotic and indicator bacteria from animal and food in 
European Union in 2008. European Food Safety Authority Journal. 8. p.1658-1919. 
Ewers C., Grobbel M., Bethe A., Wieer H., Guenther S. (2011) Extended-spectrum β-
lactamase-producing gram negative bacteria in companion animals: action is early 
warranted! Berliner und Münchener tierärztliche Wochenschrift  124. p.10-17. 
Ewers C., Bethe A., Semmler T., Guenther S. (2012) Extended-spectrum β-lactamase-
producing and AmpC producing Escherichia coli from livestock and companion 
animals, and their putative impact and public health: a global perspective. Clinical 
Microbiology and infection. 18. p. 646-655.  
Food Agriculture Organization of the United Nations (FAO). (2016) The FAO Action 
Plan on Antimicrobial Resistance 2016-2020: Supporting the food and agriculture 
sectors in implementing the Global Action Plan on Antimicrobial Resistance to 
minimize the impact of antimicrobial resistance. [Online], Available from: 
http://www.fao.org/3/a-i5996e.pdf. [Accessed 12
th
 December 2016]. 
 Forbs B. A., Sahm D. F. and Weissfeld A. S. (2007) Bailey and Scott’s Diagnostic 
Microbiology. 12th edition.  Ed Mosby Elsevier, Philadelphia. 
 
Geser N., Stephan R., Hächler H. (2012) Occurrence and characteristics of extended-
spectrum β-lactamases (ESBL)-producing Enterobacteriaceae in food producing 
animals, minced meat and raw milk. BMC Veterinary Research. 8. p .2-9. 
Hansen L. H., Jensen L. B., Sorensen H. I., Sorensen S. J. (2007) Substrate specificity 
of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric 
bacteria. Journal of Antimicrobial Chemotherapy. 60. p.145-147. 
Hansen L. H., Johansen E., Burmolle M., Sorensen A. H., Sorensen S. J. (2004) 
Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in 
Escherichia coli. Antimicrobial Agents and Chemotherapy. 48. p .3332-3337. 
Jacoby G. A. (2005) Mechanism of resistance to Quinolones. Clinical Infectious 
Disease. 41 Suppl. 2. p. S120-S126. 
26 
 
Jacoby G.A. (2009) AmpC beta-lactamases. Clinical Microbiology. 22. P. 161–182. 
 
Kim B. K., Park C. H., Kim C. J., Kim E. C., Jacoby G. A., Hooper D. C. (2009) 
Prevalence of plasmid-mediated quinolone resistance determinants over a 9-years 
period. Antimicrobial Agents and Chemotherapy. 53. p .639-645. 
 
Kluytmans J. A., Overdevest I. T., Willemsen I., Klutmans-van den Berg M. F., 
Zwaluw K., Heck M., Vandernbroucke-Grauls C., Savelkoul P. H., Johnston B. D., 
Gordon D., Johnson J. R. (2013) Extended-spectrum β-Lactamase-Producing 
Escherichia coli from retail chicken meat and humans: Comparison of strains, plasmids, 
resistance genes, and virulence factors. Clinical Infectious Disease. 56. p. 478-487. 
Kolar M., Bardon J., Chroma M., Hricova M. K., Stosova T., Sauer P., Koukalova. 
(2010) ESBL and AmpC beta-lactamase-producing Enterobacteriaceae in poultry in the 
Czech Republic. Veterinari Medicina. 55. p.119-124. 
Kojima A., Ishii Y., Ishihara K., Esaki H., Asai T., Oda C., Tamura Y., Takahashi T., 
Yamaguchi K. (2005) Extended-spectrum-beta-lactamase-producing Escherichia coli 
strains isolated from farms animals from 1999 to 2002: report from the Japanese 
Veterinary Antimicrobial Resistance Monitoring Program. Antimicrobial Agents and 
Chemotherapy. 49. p. 3533-3537. 
Leverstain-van Hall M. A., Dierikx C. M., Cohen Stuart J. C.,  Voets G. M., Van Den 
Munckhof  M. P., Van Essen-Candbergen A., Platteel T., Fluit A. C. Van Den Sande-
Bruinsma N., Scharinga J., Bonten M. J. M., Mevius D. J. and behalf of the ESBL 
Nation Surveillance Working Group. (2011) Dutch patients, retail chickens meat and 
poultry share the same ESBL genes, plasmids and strains. Clinical Microbiology and 
Infection. p. 873-880. 
Li. L, Feng S., Li Jinnian, Wu C., Wang Y., Ruan X., Zeng M. (2014) Prevalence and 
Characteristics of Extended-Spectrum ß-Lactamase and Plasmid-Mediated 
Fluoroquinolone resistance genes in Escherichia coli isolated from chickens in Anhui 
province, China. Plos One. 9. p. 104356-104362. 
Marshall B. M. and Levy S. B. (2011) Food Animals and Antimicrobials: Impacts on 




Martínez-Martínez, L., Pascual, A. & Jacoby, G. A. (1998) Quinolone resistance from a 
transferable plasmid. Lancet. 351. p. 797–9. 
Mesa R. J., Blanc V., Blanch A. R., Cortes P., Gonzáles J. J., Lavila S., Miró E., 
Muniesa M., Saco M., Tortola M. T., Mirelis B., Coll P., Llagostera M., Prats G, 
Navarro F. (2006) Extended–spectrum beta-lactamase-producing Enterobacteriaceae in 
different environments (humans, food, animals farms and sewage). Journal of 
Antimicrobial Chemotherapy. 58. p. 211-215. 
Meyer E., Gastmeier P., Kola A., Schwab F. (2012) Pet animals and foreign travel are 
risk factors for colonization with extended spectrum β-lactamase-producing Escherichia 
coli. Infection. 40. p.685-692. 
Pitout J. D. D. (2012) Extra-intestinal Pathogenic Escherichia coli: A Combination of 
Virulence with Antibiotic Resistance. Frontiers in Microbiology. 3. p.1-7.  
Pitout J. D. D. and Laupland K. B. (2008) Extended-spectrum β-lactamase-producing 
Enterobacteriaceae: an emerging public-health concern. Lancet Infectious disease. 8. 
p.159–166. 
Platteel T. N., Leverstain-van Hall M. A., Cohen Stuart J. W., Voets G. M., Van Den 
Munckhof M. P., Scharringa J., Van de Sande N., Fluit A. C., Bonten M. J. and behalf 
of the ESBL Nation Surveillance Working Group. (2013) Differences in antibiotic 
susceptibility of human Escherichia coli with poultry associated and non-poultry 
associated extended spectrum beta-lactamases. European Journal of Clinical 
Microbiology and Infectious Diseases. 32. p. 1091-1095. 
Sader H. S. (2004) O uso de antimicrobianos promotores de crescimento contribui para 
resistência a antibióticos? Anais Fundação Apinco de Ciência e Tecnologia Avícola, 
Campinas, Brasil. p. 211-3217. 
Salyers A. A., Gupta A. and Wang Y. (2004) Human intestinal bacteria as reservoir for 
antibiotic resistance genes. Trends in Microbiology. 12. p.412-416. 
Santamaria A. F. (2010) Mechanism of fluoroquinolone resistance in Escherichia coli, 
Salmonella typhimurium and Yersinia enterocolitica: Influence of expression of 
virulence factors. Doctoral Thesis.  Universitat de Barcelona. 
28 
 
Smet A., Martel A., Persoons, D., Dewulf J., Heyndrickx M., Claeys G., Lontie M., Van 
Meensel B., Herman L., Haesebrouck F., Butaye P. (2010) Characterization of extended 
spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and 
non-hospitalized patients: emergence of CTX-M-15 producing strains causing urinary 
tract infections. Microbial Drug Resistance. 16. p. 129-134. 
Strahilevitz S. J., Jacoby G. A., Hooper D. C., Robicsek A. (2009) Plasmid-mediated 
quinolone resistance: a multifaceted threat. Clinical Microbiology Reviews. 22. p. 664-
689. 
Todar K. (2014) Bacterial Resistance to Antibiotics. [Online] Available from: 
http://textbookofbacteriology.net/resantimicrobial.html.  [Accessed: 21th September 
2014]. 
Tran J. H., Jacoby G. A., Hooper D. C. (2005) Integration of plasmid-encoded 
quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrobial 
Agents and Chemotherapy. 49. p. 118-125. 
Warren R. E., Ensor V. M., O’Neill P, Buter V., Tayor J., Nye K., Harvey M., 
Livermore M. D., Woodford N., Hawkey P. M. (2008) Imported chicken meat as a 
potential source of quinolone-resistance Escherichia coli producing extended-spectrum 
beta-lactamases in the UK. Journal of Antimicrobial Chemotherapy. 61.p . 404-8. 
Winn W., Alen S., Koneman E., Procop G., Schreckenberger P. and Woods G. (2010) 
Diagnóstico Microbiológico: Texto e Atlas Colorido. 6ª edição.  Guanabara Koogan, 
Rio de Janeiro.  
Witte W. (1998) Medical consequences of antibiotic use in agriculture, Science. 279. p. 
996-7. 
World Health Organization (WHO). (2001) WHO Global Strategy for Containment of 
Antimicrobial Resistance. [Online], Available from:  
http://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf.  [Accessed: 12th 
August 2015]. 
World Health Organization (WHO). (2014) Antimicrobial resistance: Global report on 







World Organization for Animal Health (OIE). (2013) Recommendations of the OIE 
global conference on the responsible and prudent use of antimicrobial agents for 




 October 2016]. 
 
World Organization for Animal Health (OIE). (2016) The OIE Strategy on 





 December 2016]. 
 
Zemelman, R., Valenzuela L., Domínguez M., Bello H., González G., Zemelman C. 
(2002) Detección de ß-lactamasas de espectro extendido en el laboratorio de 


















The following manuscript emanated from the study: 
 
Faife, S.L., Osei Sekyere, J., Govinden, U., Zimba, T., Chenia, H.Y., Sundsfjord, A., 
and Essack, S.Y.  Extended Spectrum β-Lactamase, Plasmid-Mediated AmpC and 
Plasmid-Mediated Fluoroquinolone-Resistance in Enterobacteriaceae from Imported 
and Locally-Produced Chicken: An Observational Study in Maputo, Mozambique.  
Journal of Food Protection (submitted)  
 
  
 Ms Sara Faife, as the principal investigator, developed the protocol, undertook the 
laboratory work and data analysis, and, prepared the manuscript. 
 Dr. J Osei Sekyere facilitated the laboratory work and data analysis, and contributed 
to the critical revision of the manuscript. 
 Dr. Usha Govinden facilitated laboratory work and data analysis and contributed to 
the critical revision of the manuscript. 
 Dr. Tomas Zimba, as a co-supervisor, facilitated the preliminary laboratory work 
and contributed to the critical revision of the manuscript. 
 Dr. Hafizah Chenia facilitated and assisted with analysis of the ERIC-PCR and 
contributed to critical revision of the manuscript. 
 Professor Arnfinn Sundsfjord, as co-supervisor, co-conceptualized the study, 
ensured quality control of preliminary laboratory work and undertook critical 
revision of the manuscript. 
 Professor Sabiha Essack, as principal supervisor, co-conceptualized the study, 
facilitated data analysis and undertook critical revision of the manuscript. 
 




Running title:  ESBL, pAmpC and fluoroquinolone resistance in chicken in Mozambique. 1 
 2 
Extended Spectrum β-Lactamase, Plasmid-Mediated AmpC and Plasmid-Mediated 3 
Fluoroquinolone-Resistance in Enterobacteriaceae from Imported and Locally-Produced Chicken: 4 



















Antimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban, 9 
South Africa 10 
2
Department of Pedagogical Planning and Laboratory Courses, Higher Institute of Health Sciences, 11 
Maputo, Mozambique 12 
3
Department of Internal Medicine and Laboratory of Microbiology, Maputo Central Hospital, 13 
Maputo, Mozambique, 14 
4
Discipline of Microbiology, School of Life Sciences, University of KwaZulu-Natal, Durban, 15 
South Africa 16 
5
Department of Medical Microbiology, Faculty of Health Sciences, University of Tromsø, 17 
Norwegian Arctic University, and Norwegian National Advisory Unit on Detection of 18 
Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital 19 
of North Norway, Tromsø, Norway 20 
Key words: antibiotic resistance; ESBL; pAmpC; CTX-M; Enterobacteriaceae; chicken. 21 
                                                          







Extended-spectrum β-lactamase (ESBL) and/or plasmid-mediated AmpC (pAmpC)-producing 24 
Enterobacteriaceae with co-resistance to fluoroquinolones are increasingly identified in food-25 
borne pathogens globally.  This study investigated ESBL- and pAmpC-mediated β-lactam 26 
resistance as well as plasmid-mediated fluoroquinolone resistance in 198 samples taken from 99 27 
frozen chickens (99 samples from the liquid thaw and 99 from carcass swabs), 33 produced in each 28 
of Brazil, South Africa and Mozambique.  Species identification was undertaken using in-house 29 
biochemical tests and antibiotic susceptibility was ascertained by the disc diffusion test following 30 
CLSI guidelines.  ESBL production was determined using the double-disk synergy test and isolates 31 
were subjected to PCR to detect the presence of blaCTX-M, blaSHV, blaTEM, blaCMY, blaMOX, blaFOX, 32 
blaDHA, qnrB, qnrD, qnrS and qepA genes. A random selection of CTX-M genes was sequenced.  33 
The 198 samples yielded 27 putative ESBL-positive isolates: Citrobacter diversus (1), Citrobacter 34 
freundii (3), Enterobacter aglomerans (1), Enterobacter cloacae (1) and Escherichia coli (21). Of 35 
the 27 isolates, 19 were from South African chicken, five from Mozambican chicken and three 36 
from Brazilian chicken. Resistance to ampicillin was 100%, followed by 88.8% to ceftriaxone, 37 
77.8% to trimethoprim-sulphamethoxazole, 74.0% to cefotaxime, 70.4% to ciprofloxacin, 66.6% 38 
to ceftazidime, 22.2% to cefoxitin and 7.6% to gentamicin. Multi-drug resistance was evident in 19 39 
(70.4%) isolates, 15 of which were from South Africa. The predominant ESBL gene 40 
was blaSHV (85%), followed by blaCTX-M (62.9%) and blaTEM (44.4%) whilst blaMOX (33, 3%) and 41 
blaDHA (33.3%) were the most common pAmpC genes.  The predominant plasmid-mediated 42 
fluoroquinolone-resistance gene was qepA (22.2%). DNA sequencing of the blaCTX-M genes 43 
putatively identified blaCTX-M-55/-79/-101/-164, with blaCTX-M-164 being most common. ERIC–PCR 44 
profiles allowed the differentiation of the E. coli and Citrobacter spp. isolates.  There was no 45 
33 
 
strong evidence of clonality, however, South African isolates shared more similarity.  qnr and 46 
qepA genes were predominantly identified in South African E. coli isolates while CTX-M and 47 
SHV genes were prevalent in isolates from diverse origins.  The Mozambican population is thus 48 
exposed to a reservoir of plasmid-mediated and hence, mobile β-lactam and fluoroquinolone 49 
resistance genes from imported, and to a lesser extent, locally-produced chicken. The complexity 50 
and diversity of mobile resistance genes combinations and permutations is of concern in the food 51 







Antibiotic resistance is a global health problem that is prevalent in the human, (food) animal and 57 
environmental health sectors. Resistance exists to all currently used antibiotics in clinical and 58 
veterinary medicine. Of particular concern is the escalating resistance to broad-spectrum β-lactam 59 
and fluoroquinolone antibiotics, the former largely attributed to extended-spectrum β-lactamases 60 
(ESBLs) and plasmid-mediated AmpC (pAmpC) enzymes and the latter increasingly mediated by 61 
plasmid-mediated qnr and qep genes.  These resistance mechanisms to both antibiotic classes have 62 
been described in food-borne pathogens (1, 3, 20). 63 
 64 
 65 
The most common ESBL genes detected in bacteria among food-producing animals are blaCTX-M 66 
enzymes, followed by blaTEM-52 and blaSHV-12 (8) and mostly from E. coli.   Reports on antibiotic 67 
resistance in food products from developing countries are minimal. As chicken is one of the most 68 
consumed foods by the Mozambican population, we undertook a study to investigate ESBL and 69 
pAmpC-mediated β-lactam resistance as well as plasmid-mediated fluoroquinolone resistance in 70 
Enterobacteriaceae isolated from imported and locally-produced chicken in Maputo, 71 




Ethical Considerations.  Ethical clearance was received from Biomedical Research Ethics 76 
Committee of the University of KwaZulu-Natal (BE473/14) and the Institutional Committee of 77 
Bioethics for Health-CIBS (TFCMCSSF01/15). 78 
35 
 
Study Sample.  Ninety-nine frozen chickens, consisting of 33 chicken imported from 79 
South Africa, 33 imported from Brazil and 33 locally produced in Mozambique, were purchased 80 
from three different supermarkets in Maputo City to form the study sample. Acquisition was done 81 
weekly during May 2015 to obtain samples from different batches. 82 
Two samples were taken from each chicken, one from the thaw liquid and the other from a swab of 83 
the internal parts of the carcass yielding a total of 198 samples from 99 chickens. The samples 84 
were cultured on ESBL-selective media (MacConkey plates supplemented with 2mg/L of 85 
ceftriaxone) plates prior to their morphological and biochemical identification to the species level.  86 
 87 
Species identification and antimicrobial susceptibility testing.  Species identification 88 
was undertaken using biochemical tests (27). Antimicrobial susceptibility testing (AST) was 89 
undertaken using the agar disc diffusion assay according to CLSI guidelines (6) against ampicillin, 90 
piperacillin-tazobactam, cefoxitin, cefuroxime, cefotaxime, ceftazidime, gentamicin, ciprofloxacin 91 
and trimethoprim-sulfamethoxazole. E. coli ATCC 25922 and E. coli A5-8 (resistant strain) were 92 
used as quality controls. 93 
 94 
Phenotypic detection of putative ESBLs, and AmpC-mediated resistance.  ESBL 95 
confirmation was done using the double-disk synergy test (DDST) using ROSCO disks containing 96 
cephalosporins (cefotaxime, ceftazidime, cefepime) with and without clavulanic acid (9). E. coli 97 
ATCC 25922 and Klebsiella pneumoniae A-43 were used as controls. The phenotypic AmpC 98 
confirmation test was based on inhibition of AmpC by cloxacillin and boronic acid derivatives (9) 99 
with E. coli ATCC 25922 and E. coli A5-8 as controls. Results were considered positive when the 100 
inhibition zones of the combined disc were ≥ 5mm compared to that of the antibiotic disc alone. 101 
36 
 
The disc diffusion method was used to determine isolates that were resistant to ciprofloxacin using 102 
CLSI breakpoints (6). 103 
 104 
DNA extraction, PCR and Electrophoresis.  Genomic DNA was extracted from overnight 105 
bacterial cultures with the GeneJET Genomic DNA Purification Kit (Thermo Scientific, USA) as 106 
per manufacturer’s guidelines. 107 
 108 
PCR amplification of ESBL, AmpC, Qnr and QepA genes was done in a final volume of 25 μL, 109 
containing 12.5 μL of Phusion Flash High-Fidelity PCR Master Mix (Thermo Scientific, USA), 110 
7.5μL of sterilized distilled water, 2 μL of each primer and 1 μL template DNA. PCR was 111 
undertaken in a T100
TM
 Thermal cycler (Bio-Rad, USA). The cycle comprised of a preliminary 112 
denaturation for 10 s at 98°C, followed by 35 cycles of denaturation at 98°C for 1s, annealing for 113 
5s and elongation at 72°C for 7 min. The annealing temperatures and primers are described in 114 
Table 1. The amplicons obtained were visualized by electrophoresis in 1.5% agarose gel for 40 115 
min at 120 V, stained with gel red and detected by ultraviolet transillumination.  116 
 117 
The PCR amplicons for a random selection of CTX–M were further purified and sequenced by 118 
Inqaba Biotec South Africa, using Sanger Dideoxy sequencing technology. Sequences were 119 
analyzed using Basic Local Alignment Search Tool, available on the website of the National 120 





ERIC-PCR was done in a total reaction volume of 10 µL, which contained 2µL of template DNA 124 
and 0.1 µL of 100 µM primers ERIC 1 and ERIC 2 (25) and 5 µL of DreamTaq Green PCR Master 125 
Mix (Thermo Scientific). PCR conditions were as follows: 94 °C for 3 min, 30 cycles of 30 s of 126 
denaturation at 94 °C, 1 min of annealing at 50 °C, 8 min of extension at 65 °C and a final 127 
elongation of 16 min at 65 °C, in an Applied Biosystems 2720 Thermal Cycler. The ERIC-PCR 128 
products were loaded into 1.0% (w/v) agarose gels and subjected to electrophoresis at 80V using 129 
1× TAE buffer. Amplification products were visualized by UV transillumination (Syngene, UK) 130 
after staining in 0.1 mg/mL ethidium bromide for 15 min. Genotypic variations were analyzed 131 
using the Gel CompareII version 6.0 software package (Applied Maths) by Jacquard and 132 




Of the 198 samples, 27 were ESBL positive: 15 from the carcass swabs and 12 from the thaw 137 
liquid from a total of 22 chickens.  Five chickens (4 from South Africa and 1 from Mozambique) 138 
yielded positive results from both the carcass swab and thaw liquid.  Of the 27 ESBL-positive 139 
isolates, 19, 5 and 3 isolates were from South African, Mozambican and Brazilian chickens, 140 
respectively.  The isolates were identified as C. diversus (n=1), C. freundii (n=3), E. aglomerans 141 
(n=1), and E. cloacae ( (n=1) and E. coli (n=21) (Table 2).   142 
 143 
Resistance to ampicillin was 100%, followed by 88.8% to ceftriaxone, 77.8% to trimethoprim-144 
sulphamethoxazole, 74.0% to cefotaxime, 70.4% to ciprofloxacin, 66.6% to ceftazidime, 22.2% to 145 
cefoxitin and 7.6% to gentamicin. Multi-drug resistance (resistance to three or more antibiotic 146 
classes) was evident in 19 (70.4%) isolates, of which 15 were from South Africa and 4 from 147 
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Mozambique.  Multi-drug resistance was not evident in the three isolates from Brazilian chicken. 148 
The predominant ESBL gene was blaSHV (85.0%), followed by blaCTX-M (62.9%) and 149 
blaTEM (44.4%). DNA sequencing of a random selection of CTX-M amplicons putatively identified 150 
blaCTX-M-55/-79/-101/-164, with blaCTX-M-164 being most common (Table 2). The most prevalent AmpC 151 
genes were blaMOX (33, 3%) and blaDHA (33.3%) whilst qepA (22.2%) was the predominant 152 
plasmid-mediated fluoroquinolone resistance gene. The majority of genes were isolated from E. 153 
coli, where SHV was the most predominant. CTX-M-55 was only detected in Citrobacter spp and 154 
blaCTX-M-79/-101/-164 were identified in E. coli.  Resistance gene content ranged from 0-9 in a myriad 155 
of permutations and combinations. 156 
 157 
Based on ERIC-PCR profiles, the E. coli isolates had similarities in banding patterns varying from 158 
4 to 15 fragments, ranging in size from 0.5 to 20 kb in length. Amplification of different intensities 159 
was observed and visual analysis of the ERIC profiles included primary, secondary and tertiary 160 
amplification. All isolates were typeable using this fingerprinting technique and profiles were 161 
reproducible on repeat amplification. The ERIC–PCR profiles allowed the differentiation of the 21 162 
E. coli isolates into 14 ERIC-types which were grouped into seven clusters (C1-7), with majority 163 
of the isolates being found in cluster 3 (Fig. 1; C3). Most of the Brazilian and Mozambican 164 
samples were observed in clusters C3-5 while South African samples shared more similarity.   165 
 166 
The ERIC-PCR fingerprint profiles of the four Citrobacter spp. isolates are shown in Figure 2. 167 
Isolates exhibited banding patterns varying from 5 to 18 fragments of 0.5 to 20 kb in length and the 168 
C. freundii isolates were not clonal.  Although the CTX-M and SHV genes were identified in 75% 169 





Plasmid-mediated antibiotic resistance to third generation cephalosporins, cephamycins and 173 
fluoroquinolones is increasingly being reported in meat products such as chicken (10, 17, 24) 174 
which is the most popular animal protein in Mozambique. In this study 198 samples, yielded 27 175 
(13.6%) ESBL-positive isolates from 22 chickens. ESBL frequency in this study was higher than 176 
the a study from Nigeria where a single isolate expressed the CTX-M-15 gene from a total sample 177 
of 96 E. coli from 96 chickens (10) and lower than a study in China where 64 (31.7%) of E. coli 178 
isolates from 202 chickens were ESBL positive (17). The majority of ESBLs were isolated in 179 
South African chicken (19) followed by Mozambican (4) and finally Brazilian chicken (3). This 180 
may be related to selection pressure of antibiotics used as growth promoters, for prophylaxis and 181 
metaphylaxis in South Africa (personal communication – Dr D Petty). E. coli was the predominant 182 
bacterial species isolated, which is consistent with the observation that E. coli are one of ESBL-183 
producing bacteria that are often isolated in greater numbers in food-producing animals (24). 184 
Similar results were found in healthy broiler chickens in Germany, where E. coli and Enterobacter 185 
cloacae were identified (21). 186 
 187 
Susceptibility testing results showed high levels of resistance to the antibiotics tested. Resistance 188 
to ampicillin was 100%, followed by 88.8% to ceftriaxone, 74% to cefotaxime, 70.4% to 189 
ciprofloxacin, 66.6% to ceftazidime and 22.2% to cefoxitin similar to that observed in a study 190 
carried out in Germany on poultry imported from Italy for ampicillin (100%) but different for 191 
cefotaxime which was higher at 94% and for ceftazidime which was lower at 30% (2).The 192 
resistance  recorded for ceftriaxone was 90.0% in a study carried out in Owerri, Nigeria to 193 
determine the presence of ESBL-producing E. coli strains from poultry, similar to our results but, 194 
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in contrast,  showed 100% resistance to ceftazidime and cefotaxime (4). In a study involving 163 195 
broiler chicken conducted in Italy the resistance rates of cefotaxime and ceftazidime were also 196 
higher, reaching 91.7% for both antibiotics (11).  197 
 198 
The β-lactam antibiotic susceptibility profiles were putatively corroborated by the ESBLs and 199 
pAmpC genes identified in 78.9% (15/19) of the South African isolates, 60.0% (3/5) of the 200 
Mozambican isolates 33% (1/3) of the Brazilian isolates (in the absence of definitive gene 201 
identification save for some CTX-M genes) (Table 2).  Examples of anomalies were E. coli A25c 202 
which carried the TEM, MOX and DHA genes but was sensitive to ceftazidime and cefoxitin, E. 203 
coli A23c which carried only the TEM gene but was resistant to all the β-lactams tested and E. coli 204 
M32c, B18c and B23d which all carried the CTX-M genes but were sensitive to cefotaxime.  205 
These anomalies point to silent or minimally expressed genes in the main while the expression of 206 
multiple ESBLs and pAmpCs of the same family cannot be discounted. For example, both 207 
inhibitor-resistant TEMs and TEM ESBLs were hypothesized in E. coli A17c.  208 
 209 
Fluoroquinolone resistance was evident only in the South African isolates. Resistance to 210 
ciprofloxacin was 70.4%, lower than that found in E. coli from retail broiler chicken in Italy (88. 211 
8%) (14) and higher than the E. coli from Germany in a study carried out in poultry imported from 212 
Italy (39%) (2,11).  In a study by Fortin et al. (2011) conducted in E. coli isolates from healthy 213 
animals from Nigeria, qepA, qnrB and qnrS were also detected, although at different frequencies 214 
with a higher prevalence of qnrS (12.5%) and a lower prevalence of qnrB (4.1%) and qepA (3.1%), 215 
(9). In Abidjan, Ivory Coast, qnrA, qnrB and qnrS were also observed and the most prevalent gene 216 
was qnrB at 14.6% (12).  Six isolates exhibited resistance in the absence of qnr and qep genes 217 
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indicating alternative mechanisms of resistance such as the chromosomal mutations in the 218 
quinolone resistance determining regions of the gyrA, gyrB, parC and parE target genes or efflux 219 
(7,13).  220 
 221 
Notwithstanding the need to definitively confirm the genotypic results, ideally by whole genome 222 
sequencing, the complexity and diversity of various mobile resistance genes combinations and 223 
permutations is of concern in the food safety context.  Co-carriage of ESBL, pAmpC and plasmid 224 
mediated fluoroquinolone resistance genes have been similarly observed in Italy by Ghodousi et 225 
al. (2015), albeit not in this complexity (11). 226 
 227 
In several studies related to the ESBL-producing bacteria in chicken, the gene most frequently 228 
isolated is blaCTX-M (21, 22), which differs from this study where the most common gene was 229 
blaSHV.  In a study carried out in Henan Province (26), the most predominant gene was blaTEM. 230 
CTX-M-55, CTX-M-79, CTXM-101 and CTX-M-164 genes were detected in this study, differing 231 
from other studies where CTX-M-1 was most prevalent (5, 16, 22). CTX-M-79 and CTXM-232 
101were found in Northeast China (Heilongjiang, Liaoning, Jilin) and in the Jiangsu province in a 233 
study characterizing ESBLs in E. coli from chickens, although with lower frequencies of 3.,6% 234 
and 0.5%, respectively (2). CTX-M-55 was only detected in C. freundii strains isolated from South 235 
African chickens while CTX-M β lactamase was characterized in E. coli isolates in a study in 236 
China (17). To our knowledge, this is the first report of the putative CTX-M-164 in chicken. 237 
 238 
Among the three countries, CTX-M-55, CTX-M-79 and CTX-M-101 were only detected in South 239 
African isolates while CTX-M-164 genes were detected in two South African and one Brazilian 240 
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chicken. The CTX-M ESBLs found in our study are dissimilar to those isolated in humans as 241 
evident from a non-systematic literature review of research published in 2008-2012, which 242 
described the prevalence of CTX-M 1, 3, 9, 14a, 14b, 15, 27 and 28 in Enterobacteriaceae from 243 
hospital and community settings in Africa (26). Other studies have, in contrast, showed similarity 244 
between ESBLs isolated from E. coli in chicken meat and humans (14).  245 
 246 
Overall, the ERIC-PCR dendogram showed extensive diversity of E. coli isolates, however, there 247 
were some isolates that demonstrated similarity, especially those of South African origin. 248 
Mozambican E. coli isolates shared some similarity with South African and Brazilian isolates. 249 
Interestingly, only South African E. coli isolates carried plasmid-mediated quinolone resistance 250 
genes while isolates from all three origins harbored ESBL and pAmpC genes in different 251 
permutations and combinations. There was no correlation between the ERIC-PCR profiles and 252 
resistance genes identified. Isolates with similar profiles demonstrated different resistance gene 253 
content, e.g., M27D (SHV) and B18C (CTX-M, TEM, CMY, MOX and DHA) in cluster C3 and 254 
A10D (CTX-M, SHV, TEM, MOX, FOX, DHA, qnrB, qnrS and qepA) and A12C (CTX-M, SHV 255 
and TEM) in cluster C1. CTX-M and SHV genes were amplified from isolates belonging to all 256 
clusters, however the qnr and qepA genes were identified in South African isolates clustering in 257 
C1-3.   258 
 259 
The results of this study showed the presence of ESBL- and pAmpC-producing and 260 
fluoroquinolone resistant bacteria in chickens consumed in Mozambique. This represents a food 261 
safety concern as the Mozambican population is exposed to a reservoir of plasmid-mediated, and 262 
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hence mobile β-lactam and fluoroquinolone resistance genes via imported, and to a lesser extent, 263 
locally produced poultry. 264 
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 380 
Table 1. Primers and Annealing Temperatures 381 
Table 2: Susceptibility Results and Resistance Genes  382 
 383 
 384 
Figure Legends 385 
 386 
Figure 1: Dendogram representing the genetic relatedness and cluster analysis of 21 E. coli 387 
isolated from South African (A), Mozambican (M) and Brazilian (B) chicken samples based on 388 
ERIC-PCR fingerprinting patterns using Jacquard index and UPGMA algorithm. The scale at the 389 
top represents percentage similarity to E. coli ATCC 25922.  Included are PCR results for ESBL 390 
(CTX-M, SHV, TEM), pAmpC (CMY, MOX, FOX, DHA) and plasmid-mediated fluoroquinolone 391 
resistance genes (qnrB, qnrD, qnrS and qepA), where (+) represents positive results and (-) 392 
negative results.  393 
 394 
Figure 2: Dendogram representing the genetic relatedness and cluster analysis of three C. freundii 395 
and a Citrobacter diversus isolated from South African (A) and Brazilian (B) chicken samples 396 
based on ERIC-PCR fingerprinting patterns using Jacquard index and UPGMA algorithm.  397 
Included are PCR results for ESBL (CTX-M, SHV, TEM), pAmpC (CMY, MOX, FOX, DHA) 398 
and plasmid-mediated fluoroquinolone resistance genes (qnrB, qnrD, qnrS and qepA), where (+) 399 










Table 1. Primers and Annealing Temperatures 408 
Gene Sequence (5´ to 3´)  Annealing temp (
O
C) Reference 
CTX-M       F -  GGTTAAAAAATCACTGCGTC 
53 (12) 
R - TTGGTGACGATTTTAGCCGC 
TEM F -  AAAATTCTTGAAGACG 
60 (23) 
R -  TTACCAATGCTTAATCA 
SHV F -  TTAACTCCCTGTTAGCCA 
56 (23) 
R -  GATTTGCTGATTTCGCCC 
CMY F - GATTCCTTGGACTCTTCAG 
50 (19) 
R - TAAAACCAGGTTCCCAGATAGC 
MOX F -  GCTGCTCAAGGAGCACAGGAT                          
50 (19) 
R -  CACATTGACATAGGTGTGGTGC 
FOX F - CACCACGAGAATAACCAT 
50 (19) 
R -  ATGTGGACGCCTTGAACT 
DHA F -  AACTTTCACAGGTGTGCTGGGT 
50 (19) 
R -  CCGTACGCATACTGGCTTTGC 
qnrB F - GGAATCGAAATTCGCCACTG 
49 (17) 
R -  TTTGCCGTTCGCCAGTCGAA 
qnrD F -  AGATCAATTTACGGGAATA 
49 (28) 
R -  AACAAGCTGAAGCGCCTG 
qnrS F -  CACTTTGATGTCGCAGAT 
49 (29) 
R -  CAACATACCCAGTGCTT 
qepA F -  CCGATGACGAAGCACAGGG 
49 (15) 
R -  CTACGGGCTCAAGCAGTTGG 




 Table 2: Susceptibility Results and Resistance Genes  411 
  412 
Country Code Species Source Antibiotic Susceptibility Β-Lactamase Genes  Plasmid-Mediated 
Fluoroquinolone Genes  
AUG CTX CAZ CTR CFX GEN AMP SXT CIP CTX-
M 









































A3d E.  
aglomerans 
Thaw S R R R R S R R R - + - - + - + + - + + 
A10c E.coli Carcass R R R R R S R R R + + + + + + + - - - + 
A10d E.coli Thaw S R R R I S R R R + + + - + + + + - + + 
A12c E.coli Carcass S I S R S S R R S CTX-
M-101 
+ + - - - - - - - - 
A13d E.coli Thaw S I R R S S R R R CTX-
M-79 
+ + - - - - - - - - 
A17c E.coli Carcass I R R R S S R R S - - + - - - - - - - - 
A19c C. diversus Carcass S R R R S S R R S CTX-
M-55 
+ + - - - - + - + + 
A20c E.coli Carcass S R R R S S R R R - + + - - - - - - - - 
A23c E.coli Carcass R R R R R S R R R - - + -  -  -  - + - - - 
A25c E.coli Carcass S I S R S S R R R - - + - + - +  - - - - 
A25d E.coli Thaw I R R R S S R R I - + - -  - -  - -  - - - 
A26c C. freundii Carcass I R R R S S R R R CTX-
M-55 
+ - - + - + + + + + 
A26d C. freundii Carcass S R R R I S R R R + + + - + - + - + - - 
A27d E.coli Thaw S R R R I S R R R - - - - - - - - - - - 
A29c E.coli Carcass S R R R S S R R R + + - - - - - - - - - 
A30
C 
E.coli Carcass S R I R S S R R R + + + - - - - - + + + 
A30d E.coli Thaw R R R R R S R R S + + + + + - +  - - - - 
A33d E.coli Thaw S R R R S S R R R CTX-
M-164 
+ - - - - - - - - - 
A32d E.coli Thaw S R R R S S R R R CTX-
M-164 





R-resistant; S-sensitive; I-intermediate; AUG - Amoxicillin/ clavulanic acid (≥26-S, 23-25-I, ≤22-R); CTX- Cefotaxime (≥18-S, 14-17-I, ≤13-R); 415 
CAZ-Ceftazidime (≥21-S, 18-20-I, ≤17-R); CTR-Ceftriaxone (≥23-S,20-22-I,≤19-R); CFX-Cefoxitin (≥18-S,15-17-I,≤14-R); GEN-Gentamicin 416 
(≥15-S,13-14-I,≤12-R), AMP-Ampicillin (≥17-S, 13-16-I, ≤13-R); SXT – Trimethoprim-sulphamethoxazole (≥16-S, 11-15-I,≤10-R); CIP-417 











B17c E.coli Carcass R S S S S S R S R - + -  -  -  -  - - - - - 
B18c E.coli Carcass R S R I R R R S S CTX-
M-164 
+ + + + - + - - - - 







M15d E. cloacae Thaw S R S R S S R R R - - -  - -   -  - - - - - 
M27c E.coli Carcass R R R R R S R S S - + - - + - + - - - - 
M27d E.coli Thaw S R S R S S R R R - + - - - - - - - - - 
M30d E.coli Thaw S R S R S I R R R + + - - - - - - - - - 
























0 10 15 20 25 
A33D E. coli + + - - - - - - - - -   
       A27D E. coli  - - - - - - - - - - - 
M32C E. coli + + - - - - - - - - - 
A20C E. coli - + + - - - - - - - - 
M30D E. coli  + + - - - - - - - - - 
A17C E. coli - - + - - - - - - - -   
M27C E. coli - + - - + - + - - - -  
A29C E. coli + + - - - - - - - - -  
A32D E. coli + + - - - - - - - - - 
 
B18C E. coli + + + + + - + - - - - 
 
M27D E. coli - + - - - - - - - - - 
 
B17C E. coli - + - - - - - - - - - 
 
A13D E. coli + + + - - - - - - - - 
 
A30C E. coli + + + - - - - - + + + 
 
A10C E. coli + + + + + + + - + - + 
A25C E. coli -                - + - + - + - - - - 
 
A25D E. coli + + - - - - - - - - - 
A23C E. coli - - + - - - - + - - - 
A30D E. coli + + - + - + + - - - - 
 
A10D E. coli + + + - + + + + - + + 
 
A12C E. coli + + + - - - - - - - - 
 
E coli ATCC 25922 
                   













A19C       C. diversus               +              +                 +             -                 +               -                 +          -                   +                     -                  - 
B23D       C. freundii                +           +            -           -                -              -              -               -                -                  -              - 
 A26D       C. freundii         -            -              -            -            -              -         -                  -                  -              -              - 




-   
 










Ninety-nine frozen chickens, consisting of 33 chicken imported from South Africa, 33 from Brazil 
and 33 locally produced in Mozambique, were purchased from three different supermarkets in 
Maputo City to form the study sample. Acquisition was done weekly during May 2015 to obtain 
samples from different batches. Two samples were taken from each chicken, one from the thaw 
liquid and the other from a swab of the internal parts of the carcass yielding a total of 198 samples 
from 99 chickens. The samples were phenotypically and genotypically tested for the presence of 
ESBL, pAmpC and plasmid-mediated quinolone resistance genes. 
 
The following were the main findings:  
 Five different bacterial species were identified from 27 positive cultures, viz., 21 E. coli, 3 
Citrobacter freundii, 1 Citrobacter diversus, 1 Enterobacter aglomerans and 1 Enterobacter 
cloacae.  
Of these, 19 were isolated from South African chicken, 5 from Mozambican and 3 from 
Brazilian chickens.  
 Resistance to ampicillin was 100%, followed by 88.8% to ceftriaxone, 77.8% to trimethoprim-
sulphamethoxazole, 74.0% to cefotaxime, 70.4% to ciprofloxacin, 66.6% to ceftazidime, 
22.2% to cefoxitin and 7.6% to gentamicin.  
Multi-drug resistance (resistance to 3 or more antibiotic classes) was evident in 19 (70.4%) 
isolates, of which 15 were from South Africa and 4 from Mozambique.   
 The predominant ESBL gene was blaSHV (85%), followed by blaCTX-M (62.9%) and 
blaTEM (44.4%) whilst blaMOX (33, 3%) and blaDHA (33.3%) were the most common AmpC 
genes.   
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 DNA sequencing of the blaCTX-M genes putatively identified blaCTX-M-55/-79/-101/-164, with blaCTX-
M-164 being most common.  To our knowledge, this is the first report of the putative CTX-M-
164 from chicken in Africa. 
 The predominant plasmid-mediated fluoroquinolone-resistance gene was qepA (22.2%).  
 The complexity and diversity of mobile resistance genes combinations and permutations is of 
concern in the food safety context. 
 Isolates did not appear to be clonal, but shared similarity particularly E. coli of South African 
origin.  No one specific ERIC-PCR profile was linked to carriage of plasmid-mediated 
resistance genes. 
 The Mozambican population is thus exposed to a reservoir of plasmid-mediated and hence, 
mobile β-lactam and fluoroquinolone resistance genes from imported, and to a lesser extent, 




 The small sample size precluded conclusions on the true prevalence of ESBL, pAmpC-
producing Enterobacteriaceae with co-resistance to fluoroquinolones in chicken locally 
produced in Mozambique and imported from South Africa and Brazil. 
 Limited resources precluded the definitive identification of all but some of the CTX-M genes 




The following recommendations emanated from this study: 
 The study should be repeated with a larger sample size to obtain representative results. 
 A similar study should be undertaken on chickens sold in informal markets to ascertain the 
nature and extent of resistance in this sector. 
 All resistance genes should be definitively identified by DNA sequencing. 
 Alternative mechanisms of resistance should be investigated as appropriate. 
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 This baseline data should engender further research to generate evidence to inform AMR 
policy in Mozambique, specifically to improve/inform agricultural practice related to growth 
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